General MedicationsINTRAVENOUSGeneric
MIVACURIUM CHLORIDE
MIVACURIUM CHLORIDE
Standard Dose
EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MIVACURIUM CHLORIDE is listed in Drugs@FDA under application 209708 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MIVACURIUM CHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 20MG BASE/10ML (EQ 2MG BASE/ML) Sponsor WOODWARD Submission history Latest submission status date: 2021-10-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview MIVACURIUM CHLORIDE is listed in Drugs@FDA under application 209708 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MIVACURIUM CHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 20MG BASE/10ML (EQ 2MG BASE/ML) Sponsor WOODWARD Submission history Latest submission status date: 2021-10-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.